$98.68
1.741.79%
At close: Sep 2, 5:00 PM EST
Invesco Biotechnology & Genome ETF Holdings
PBEARCA
As of Aug 05, 2026
Number of Stock Holdings
30
Number of Bond Holdings
-
Total Holdings
33
Number of ETFs
-
Invesco Biotechnology & Genome ETF (ARCA:PBE), Top Holdings
Invesco Biotechnology & Genome ETF (ARCA: PBE)
FAQ
How has PBE ETF performed?
The PBE ETF is currently trading at $0, which represents a 0% change. Over the past 52 weeks, the ETF has traded as high as $98.82 and as low as $67.69.
What is the expense ratio for PBE?
The expense ratio of PBE is 0.58%. This represents the annual fee that all funds or ETFs charge their shareholders.
What is the Assets Under Management (AUM) for PBE?
The total Assets Under Management (AUM) for PBE is 470.57M. This represents the total market value of the assets managed by the ETF.
What is the investment style for PBE?
PBE follows a Small Cap Blend investment style.
What are the top holdings for PBE?
The top holdings of PBE include: GILD (4.5%), AMGN (5.17%), REGN (5.33%), BIIB (4.81%), UTHR (3.99%). These represent the largest positions in the ETF's portfolio.
What is the average daily trading volume for PBE?
Average daily volume data for PBE is currently not available.
